Independent fund research. Built on SEC filings.

How we research funds

ETF · Global Stock · Franklin Templeton

Aztlan Global Stock Selection DM SMID ETF (AZTD)

Ticker AZTD · Since 2022-08-17 · · Holdings as of Jul 31, 2026

Expense ratio
0.75%$75/yr per $10k
1-yr return
+7.0%as of Dec 2024
Net assets
$37.9Mall share classes
Holdings
50

Bottom line

Is AZTD a good fund? The bottom line

AZTD is a managed global stock ETF from Franklin Templeton.

Its expense ratio is 0.75% — about $75 a year on every $10,000 invested, cheaper than 74% of global stock funds we track.

It returned +7.0% over one year (as of Dec 31, 2024, per its prospectus).

With $37.9 million in net assets and 50 holdings, its largest position is DaVita Inc (3.1%) and the top 10 make up 25.9% of the portfolio.

What to watch

  • Small fund ($37.9 million) — small funds are likelier to close
  • High turnover (316% a year) can mean more taxable distributions

Updated Nov 19, 2026

What AZTD invests in

The Aztlan Global Stock Selection DM SMID ETF (the Fund) seeks to track the performance, before fees and expenses, of the Solactive Aztlan Global Developed Markets SMID Cap Index (the Index, or the Global Index).

The Fund uses a passive management (or indexing) approach to track the performance, before fees and expenses, of the Index. The Index is based on a proprietary methodology created by Aztlan Equity Management, LLC (Aztlan) that follows a non-discretionary, rules-based methodology to determine the universe of potential Index components. The Index is owned, calculated, administered, and published by Solactive AG (Solactive). Solactive Aztlan Global Developed Markets SMID Cap Index The Index is comprised of equity securities of companies from the following three developed markets (DM) regions: North America (United States and Canada), Western Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom), and Asia (Australia, Japan and New Zealand, but excluding Hong Kong and Singapore).…

From the fund's prospectus (filed Nov 24, 2025).

AZTD performance

Fund calendar-year total returns, 2023–2024 2023: +11.1%; 2024: +7.0% +11.1% 2023 +7.0% 2024
Fund gain (+)
Average annual total returns
1 yr5 yr10 yr
AZTD+7.0%——
Global Stock median+15.2%+7.6%+9.5%

Source: Fund prospectus, as of Dec 31, 2024

Full AZTD performance history →

What AZTD costs

On a $10,000 investment, AZTD's 0.75% expense ratio costs about $75 a year. The prospectus estimates $930 in total costs over 10 years (assuming 5% annual returns). The median global stock fund charges 0.95%.

See the full AZTD fee table →

AZTD top 10 holdings

#Holding% of fund
1DaVita Inc DVA3.06%
2Enova International Inc ENVA2.96%
3Medpace Holdings Inc MEDP2.90%
4Cybozu Inc 47762.51%
5Happinet Corp 75522.45%
6Halozyme Therapeutics Inc HALO2.45%
7Virtu Financial Inc VIRT2.40%
8Docusign Inc DOCU2.40%
9Food & Life Cos Ltd 35632.40%
10Sterling Infrastructure Inc STRL2.38%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 25.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to AZTD

More funds like AZTD →

AZTD FAQ

What is the expense ratio of AZTD?
AZTD's expense ratio is 0.75%, which works out to about $75 a year for every $10,000 invested. The prospectus estimates total costs of $930 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is AZTD a good investment?
It depends on your goals, but the data points to: small fund ($37.9 million) — small funds are likelier to close; high turnover (316% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does AZTD hold?
AZTD's largest holdings are DaVita Inc (3.1%), Enova International Inc (3.0%), Medpace Holdings Inc (2.9%), Cybozu Inc (2.5%), Happinet Corp (2.5%). It holds 50 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages AZTD?
AZTD is offered by Franklin Templeton through Tidal Trust I.